Table 2.
Clinicopathological characteristics of the cohort included in the study (n = 213)
| Characteristic | Control cohort | Cancer cohort |
|---|---|---|
| n = 136 | n = 77 | |
| Age (years) | ||
| Mean (range) | 50.4 (23–88) | 66.4 (47–86) |
| Sex, no. (%) | ||
| Male | 72 (52.9) | 65 (84.4) |
| Female | 64 (47.1) | 12 (15.6) |
| Ethnicity, no. (%) | ||
| Caucasian | 100 (73.5) | 74 (96.1) |
| Asian | 22 (16.2) | 2 (2.6) |
| African-American | 3 (2.2) | 0 (0) |
| Hispanic | 1 (0.7) | 1 (1.3) |
| Other | 0 (0) | 0 (0) |
| Not available | 10 (7.4) | 0 (0) |
| Tumor type, no. (%) | ||
| NMIBC, TCC | n.a | 66 (85.7) |
| MIBC, TCC | n.a | 10 (13.0) |
| AC | n.a | 1 (1.3) |
| SCC | n.a | 0 (0) |
| Tumor grade, no. (%) | ||
| Low grade | n.a | 10 (13.0) |
| High grade | n.a | 51 (66.2) |
| Not Available | n.a | 16 (20.8) |
NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, TCC transitional cell carcinoma, AC adenocarcinoma, SCC squamous cell carcinoma, n.a. not applicable